2月28日(火)
● LED技術
Lynk Labs, Acuity Brands and Schneider Electric Settle Patent Dispute and Reach License Agreement
Lynk Labs, Acuity Brands and Schneider Electric Settle Patent Dispute and Reach License Agreement
● パテントトロール・エオラステクノロジーズ・グーグル
Famous patent “troll’s” lawsuit against Google booted out of East Texas
Famous patent “troll’s” lawsuit against Google booted out of East Texas
● 無線通信方法・特許適格性
Fitbit, Inc. v. AliphCom (N.D. Cal. 2017)
Fitbit, Inc. v. AliphCom (N.D. Cal. 2017)
2月27日(月)
● マジックバンド・ディズニー・ブライアン
Disney sued by three brothers in wristband clash
Disney sued by three brothers in wristband clash
● 特許消尽・プラントロニクス・レックスマーク
Plantronics files amicus brief in patent exhaustion suit
Plantronics files amicus brief in patent exhaustion suit
● サプリメントMigreLief・Akeso Health Sciences・United Natural Foods
Migraine supplement at centre of patent battle
Migraine supplement at centre of patent battle
● 遺伝子検査キット・ライフテクノロジーズ・プロメガ
US Supreme Court Holds That Exporting One Component of Invention Abroad Does Not Suffice for Patent Infringement
US Supreme Court Holds That Exporting One Component of Invention Abroad Does Not Suffice for Patent Infringement
● C型肝炎薬SOVALDI(ソホスブビル)・ギリアド・メルク
Gilead seeks to overturn $2.54 bln verdict in hepatitis C drug case
Gilead seeks to overturn $2.54 bln verdict in hepatitis C drug case
2月26日(日)
● ゲノム編集・CRISPR-Cas9
Lengthy battle looms in U.S. over revoluntionary gene-editing patent rights
Lengthy battle looms in U.S. over revoluntionary gene-editing patent rights
2月24日(金)
● コピー機・MPHJ v. Ricoh
Federal Circuit Case Highlights the Importance of a Well Designed Provisional Patent Application Strategy
Federal Circuit Case Highlights the Importance of a Well Designed Provisional Patent Application Strategy
● ソフトウェア・Trading Technologies International v. CQG
Federal Circuit Rules Software Patent for a User Interface is Patentable Subject Matter
Federal Circuit Rules Software Patent for a User Interface is Patentable Subject Matter
● ソフトウェア・アップル v. Ameranth
Federal Circuit Knocks Out Patents After CBM Challenge
Federal Circuit Knocks Out Patents After CBM Challenge
● 遺伝子検査キット・ライフテクノロジーズ・プロメガ
Life Technologies wins Supreme Court patent case
Life Technologies wins Supreme Court patent case
● Zohydro ER (酒石酸水素ヒドロコドン)・Pernix・Actavis
PERNIX THERAPEUTIC HOLDINGS, INC. (NASDAQ:PTX) PREVAILS IN PATENT LAWSUIT
PERNIX THERAPEUTIC HOLDINGS, INC. (NASDAQ:PTX) PREVAILS IN PATENT LAWSUIT
● セルトリオン・ハーセプチン(トラスツズマブ)
Celltrion Files Petition for IPR of Genentech’s Trastuzumab Patent
Celltrion Files Petition for IPR of Genentech’s Trastuzumab Patent
● ジェネンテック・蛋白質のフォールディング
PTAB Denies Institution of IPR on Genentech’s Protein Folding Patent
PTAB Denies Institution of IPR on Genentech’s Protein Folding Patent
2月23日(木)
● 遺伝子検査キット・ライフテクノロジーズ・プロメガ
Promega Corp. loses patent case before U.S. Supreme Court
Promega Corp. loses patent case before U.S. Supreme Court
● Zohydro ER (酒石酸水素ヒドロコドン)・Pernix・Actavis
Pernix Therapeutics (PTX) to Acquire Zogenix's (ZGNX) Zohydro ER Business
Pernix Therapeutics (PTX) to Acquire Zogenix's (ZGNX) Zohydro ER Business
2月22日(水)
● ネットワークスイッチ・ルータ・AT&T・Broadcom・Plectrum
AT&T and Broadcom targeted in patent claims
AT&T and Broadcom targeted in patent claims
● ジルコア v. ストラウマン・特許適格性
Zircore v. Straumann: A Method of Manufacturing a Physical Object Is Not an Abstract Idea
Zircore v. Straumann: A Method of Manufacturing a Physical Object Is Not an Abstract Idea
● アロキシ(パロノセトロン)・Dr. Reddy's
Generic Found to Infringe Valid Patent Claims Covering Helsinn’s Aloxi® Product
Generic Found to Infringe Valid Patent Claims Covering Helsinn’s Aloxi® Product
● 2017年の医薬特許切れ
Top 10 U.S. patent losses of 2017
Top 10 U.S. patent losses of 2017
2月21日(火)
● グルーポン・特許適格性
Groupon succeeds in Fed Circuit patent fight
Groupon succeeds in Fed Circuit patent fight
● 植込み型心臓機器・ボストン・サイエンティフィック
U.S. top court rejects Boston Scientific's patent licensing appeal
U.S. top court rejects Boston Scientific's patent licensing appeal
● アップル v. Ameranth
Federal Circuit Knocks Out Patents After CMB Challenge
Federal Circuit Knocks Out Patents After CMB Challenge
● アバスチンのバイオシミラー
Roche Sues Amgen Over Avastin Biosimilar (AMGN)
Roche Sues Amgen Over Avastin Biosimilar (AMGN)
● インフリキシマブのバイオシミラー
Janssen v. Celltrion: Trial Postponed, Briefing and Hearings Scheduled on Standing, Damages Issues
Janssen v. Celltrion: Trial Postponed, Briefing and Hearings Scheduled on Standing, Damages Issues
● ゲノム編集・CRISPR-Cas9
How Much Is a CRISPR Patent License Worth?
How Much Is a CRISPR Patent License Worth?
● バイオシミラー・パテントダンス
Will You, Won't You Join Biosimilar Patent Dance?
Will You, Won't You Join Biosimilar Patent Dance?
2月20日(月)
● マイクロソフト・フィリップス
Microsoft files IPR against Philips patent asserted against Taiwanese consumer electronics firms
Microsoft files IPR against Philips patent asserted against Taiwanese consumer electronics firms
2月19日(日)
● ウォーターバルーン・Tinnus v. Telebrands
Can You Be Reasonably Certain a Water Balloon Is Substantially Filled? Indefiniteness in Tinnus v. Telebrands
Can You Be Reasonably Certain a Water Balloon Is Substantially Filled? Indefiniteness in Tinnus v. Telebrands
● 潰瘍性大腸炎薬リアルダ(メサラミン)・シャイア v. ワトソン
Federal Circuit Finds "Consisting Of" Requires Reversing Infringement Of Shire Lialda Patent
Federal Circuit Finds "Consisting Of" Requires Reversing Infringement Of Shire Lialda Patent
2月17日(金)
● コピー機・MPHJ v. Ricoh
The Removal of Matter from the Provisional Application is Significant to the Interpretation of the Claims in the Non-Provisional Application
The Removal of Matter from the Provisional Application is Significant to the Interpretation of the Claims in the Non-Provisional Application
● データ処理システム・パーソナルウェブ v. アップル
Personal Web Technologies, LLC v. Apple, Inc. (Fed. Cir. 2017)
Personal Web Technologies, LLC v. Apple, Inc. (Fed. Cir. 2017)
● クアルコム・アップル
Qualcomm CEO: Apple Lawsuit Will Be Settled
Qualcomm CEO: Apple Lawsuit Will Be Settled
● アバスチンのバイオシミラー・ロシュ・アムジェン
Roche lawsuit blasts Amgen for 'about face' on biosimilar patent fights
Roche lawsuit blasts Amgen for 'about face' on biosimilar patent fights
● サンド v. アムジェン
Summary of Sandoz’s Opening Brief in Sandoz v. Amgen
Summary of Sandoz’s Opening Brief in Sandoz v. Amgen
2月16日(木)
● ブラックベリー・ノキア
BlackBerry Launches Patent Lawsuit Against Nokia
BlackBerry Launches Patent Lawsuit Against Nokia
● Chrome・マルウェア対策ソフトウェア
Google ordered to pay damages for Chrome patent violation
Google ordered to pay damages for Chrome patent violation
● ゲノム編集・CRISPR-Cas9
Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight
Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight
● アロキシ(パロノセトロン)・Dr Reddy's
Dr Reddy's Hits 52-Week Low On US Court Ruling On Patent Infringement
Dr Reddy's Hits 52-Week Low On US Court Ruling On Patent Infringement
● 潰瘍性大腸炎薬リアルダ(メサラミン)・シャイア v. ワトソン
Shire Development LLC v. Watson Pharmaceuticals Inc. (Fed. Cir. 2017)
Shire Development LLC v. Watson Pharmaceuticals Inc. (Fed. Cir. 2017)
● フィルグラスチム・アムジェン v. アポテックス
Briefing Complete in Appeal in Amgen v. Apotex
Briefing Complete in Appeal in Amgen v. Apotex
2月15日(水)
● アップル・パーソナルウェブテクノロジー
Apple loses data patent suit at Federal Circuit
Apple loses data patent suit at Federal Circuit
● 潰瘍性大腸炎薬リアルダ(メサラミン)・シャイア v. ワトソン
Strong Presumption that Markush Claim Elements are Closed to Additional Elements
Strong Presumption that Markush Claim Elements are Closed to Additional Elements
● カンバーランド v. マイラン
FDA Request for Justification Found to Provide a Mere Research Suggestion—Not Conception of Claimed Formulation
FDA Request for Justification Found to Provide a Mere Research Suggestion—Not Conception of Claimed Formulation
2月14日(火)
● Faslodex(フルベストラント)・アストラゼネカ・Dr. Reddy's
AstraZeneca sues Dr Reddy's over breast cancer drug
AstraZeneca sues Dr Reddy's over breast cancer drug
● Praluent(アリロマム・抗PCSK9抗体)・サノフィ・リジェネロン
Update: Praluent® Injunction Stayed by Fed. Circuit
Update: Praluent® Injunction Stayed by Fed. Circuit
2月13日(月)
● Java API・オラクル・グーグル
Oracle refuses to let go of Google for using Java in its Android operating system
Oracle refuses to let go of Google for using Java in its Android operating system
● 潰瘍性大腸炎薬リアルダ(メサラミン)・シャイア v. ワトソン
Federal Circuit reverses infringement ruling in Shire v Watson
Federal Circuit reverses infringement ruling in Shire v Watson
● 糖尿病薬アクトス(ピオグリタゾン)・武田薬品
Second Circuit revives competition suit against Takeda
Second Circuit revives competition suit against Takeda
● 多発性硬化症薬コパキソン(グラチラマー酢酸塩)
Moving From Everyday Dosing To Less Frequent Dosing Is Obvious
Moving From Everyday Dosing To Less Frequent Dosing Is Obvious
2月12日(日)
● インテレクチュアルベンチャーズ・東芝
Jury Hands Intellectual Ventures A Win In Toshiba IP Row
Jury Hands Intellectual Ventures A Win In Toshiba IP Row
2月10日(金)
2月9日(木)
● マイクロソフト・顧客保護
Microsoft Gets Serious About Customer Protection, Launches Microsoft Azure IP Advantage [VIDEO]
Microsoft Gets Serious About Customer Protection, Launches Microsoft Azure IP Advantage [VIDEO]
● 金融証券取引・グラフィカル・ユーザ・インタフェース
Graphical User Interface Patent Claims Found Eligible
Graphical User Interface Patent Claims Found Eligible
● アップル v. サムスン
Federal Circuit remands Apple v. Samsung design patent case to Judge Koh in Northern California
Federal Circuit remands Apple v. Samsung design patent case to Judge Koh in Northern California
● アムジェン v. サノフィ・抗PCSK9抗体
Amgen vs. Sanofi – appeals court suspend patent injunction
Amgen vs. Sanofi – appeals court suspend patent injunction
2月8日(水)
● Netflix・トロール
Patent Troll Files Lawsuit Against Netflix, Vimeo & Others; Claims Patent Over Download Features, Offline PlayBack
Patent Troll Files Lawsuit Against Netflix, Vimeo & Others; Claims Patent Over Download Features, Offline PlayBack
● アップル v. サムスン
Apple v. Samsung patent case sent back to lower courts to determine if damages retrial is necessary
Apple v. Samsung patent case sent back to lower courts to determine if damages retrial is necessary
● TCハートランド v. クラフトフーズ
TC Heartland v. Kraft: Awaiting a 2017 Supreme Court Decision with Potentially Significant Implications for Patent Litigation
TC Heartland v. Kraft: Awaiting a 2017 Supreme Court Decision with Potentially Significant Implications for Patent Litigation
● 多発性硬化症薬Copaxone(グラチラマー酢酸塩)
Moving From Everyday Dosing to Less Frequent Dosing is Obvious
Moving From Everyday Dosing to Less Frequent Dosing is Obvious
2月7日(火)
● Piggly Wiggly・ビデオモニタリング
Piggly Wiggly sued for patent infringement
Piggly Wiggly sued for patent infringement
● インターネットプロトコルテレビジョン
MediaTube appeals dismissal of $350-million IPTV patent infringement lawsuit against Bell
MediaTube appeals dismissal of $350-million IPTV patent infringement lawsuit against Bell
● AMD・GPU技術
AMD Files A Lawsuit Against LG, Vizio, MediaTek and Sigma Designs For Infringing Its GPU Technology
AMD Files A Lawsuit Against LG, Vizio, MediaTek and Sigma Designs For Infringing Its GPU Technology
● TCハートランド v. クラフトフーズ
TC Heartland v. Kraft: Awaiting a 2017 Supreme Court Decision with Potentially Significant Implications for Patent Litigation
TC Heartland v. Kraft: Awaiting a 2017 Supreme Court Decision with Potentially Significant Implications for Patent Litigation
● Endo Pharms・Opana ER(オキシモルホン塩酸塩)
Endo Pharms. Inc. v. Amneal Pharms. LLC
Endo Pharms. Inc. v. Amneal Pharms. LLC
● Dr Reddy’s・Kuvan(サプロプテリン二塩酸塩)
Dr Reddy’s sued for patent infringement
Dr Reddy’s sued for patent infringement
● インフリキシマブのバイオシミラー
Inflectra® Biosimilar Patent Litigation—The Remedies Dispute
Inflectra® Biosimilar Patent Litigation—The Remedies Dispute
● 多発性硬化症薬Copaxone(グラチラマー酢酸塩)
Patent Claims Directed to Treatment for Multiple Sclerosis Invalid as Obvious
Patent Claims Directed to Treatment for Multiple Sclerosis Invalid as Obvious
2月6日(月)
● Snapchat
Snapchat owner caught up in IP suits
Snapchat owner caught up in IP suits
● オレフィンメタセシス触媒
Evonik celebrates victory in US patent litigation
Evonik celebrates victory in US patent litigation
2月5日(日)
● AMD・グラフィックス処理アーキテクチャ
AMD files a patent infringement complaint against LG, MediaTek, Sigma Designs and Vizio
AMD files a patent infringement complaint against LG, MediaTek, Sigma Designs and Vizio
● 抗菌薬Invanz(エルタペネム)・メルク v. ホスピーラ
Merck Sharp & Dohme Corp. v. Hospira Inc.
Merck Sharp & Dohme Corp. v. Hospira Inc.
● レミケード(インフリキシマブ)・ヤンセン
Janssen Files Opening Appeal Brief in Attempt to Revive Remicade® Patent
Janssen Files Opening Appeal Brief in Attempt to Revive Remicade® Patent
● アムジェン v. サンド
Supreme Court Grants Certiorari in Amgen v. Sandoz
Supreme Court Grants Certiorari in Amgen v. Sandoz
2月3日(金)
● ファイル検索ソフトウェア
Speedtrack Inc. v. Amazon.com, Inc. (N.D. Cal. 2017)
Speedtrack Inc. v. Amazon.com, Inc. (N.D. Cal. 2017)
● Investel・Snap
Investel Sues Snap Inc. to Invalidate Key Patent
Investel Sues Snap Inc. to Invalidate Key Patent
● ナゾネックス(モメタゾンフランカルボン酸エステル水和物)
Merck Sharp & Dohme Corp. v. Teva Pharms. USA, Inc.
Merck Sharp & Dohme Corp. v. Teva Pharms. USA, Inc.
● カンバーランド v. マイラン
Communication of an Idea that Makes the Claimed Invention Obvious is Not Enough to Show Derivation
Communication of an Idea that Makes the Claimed Invention Obvious is Not Enough to Show Derivation
2月2日(木)
● AMD・グラフィックス処理アーキテクチャ
AMD Patent Infringement Complaint Filed Against LG, Vizio And Sigma
AMD Patent Infringement Complaint Filed Against LG, Vizio And Sigma
● Orexo社・Zubsolv(ブプレノルフィン/ナロキソン舌下錠)
Orexo AB v. Actavis Elizabeth LLC
Orexo AB v. Actavis Elizabeth LLC
● テバ・糖尿病薬Victoza(リラグルチド)
Teva Confirms Generic Victoza® Patent Challenge in the United States
Teva Confirms Generic Victoza® Patent Challenge in the United States
● テバ・多発性硬化症薬Copaxone(グラチラマー酢酸塩)
Are Teva Pharmaceutical's Best Days Behind It?
Are Teva Pharmaceutical's Best Days Behind It?
● 抗PCSK9抗体 Amgen v. Regeneron
Amgen claims Sanofi, Regeneron 'resort to hyperbole,' 'scare tactics' in PCSK9 appeal
Amgen claims Sanofi, Regeneron 'resort to hyperbole,' 'scare tactics' in PCSK9 appeal
2月1日(水)
● マイラン v. オーロビンド
Mylan Institutional LLC v. Aurobindo Phama Ltd
Mylan Institutional LLC v. Aurobindo Phama Ltd
● マイラン・テバ・多発性硬化症治療薬Copaxone(グラチラマー酢酸塩)
District Court Rules Against Teva in Copaxone Patent Lawsuit
District Court Rules Against Teva in Copaxone Patent Lawsuit